Clinical Study
Kinetics and Determining Factors of the Virologic Response to Antiretrovirals during Pregnancy
Table 1
Demographics and baseline characteristics of HIV infection.
| | Characteristic | or Median (% or IQR) |
| | Patients | 105 | | One pregnancy with CHIP | 93 (89) | | Two pregnancies with CHIP | 12 (11) | | Maternal age at delivery | 30 (26, 34) | | Race | | | White | 72 (68.6) | | Black | 31 (29.5) | | Other | 2 (1.9) | | Ethnicity | | | Hispanic | 41 (39) | | Not Hispanic | 64 (61) | | Country of origin | | | African countr | 15 (14) | | Mexico | 17 (16) | | USA | 66 (63) | | Other | 4 (4) | | Unknown | 3 (3) | | HIV risk factor | | | IV drug use | 12 (11) | | Heterosexual sex | 97 (92) | | Transfusion | 5 (5) | | HIV diagnosis | | | Prior to first pregnancy at CHIP | 70 (67) | | During pregnancy | 35 (33) | | ARV experience | | | Naive | 51 (44) | | Experienced on therapy at the onset of pregnancy | 29 (25) | | Experienced off therapy at the onset of pregnancy | 30 (26) | | Unknown | 7 (5) | | Plasma HIV RNA at first visit | 109 pregnancies | | Median (range) | 2657 (225, 16700) | | 400 copies/mL | 78 (72) | | CD4+ count at first visit | 108 pregnancies | | Median (range) | 450 (269, 628) | | 200 cells/ | 13 (12%) |
|
|
Includes Ethiopia, Liberia, Nigeria, Kenya, and Somalia.
Nine patients have more than one risk factor.
|
